脊柱融合术前模拟阿片类药物撤药:模拟数据,真实世界洞察
该回顾性队列研究利用Humana商业保险数据(2007年至2017年第一季度)分析颈段及腰/胸腰段脊柱融合患者,将术前一年吗啡当量超过5000定义为慢性阿片类药物使用,并根据末次阿片类药物处方(供应量少于14天)与手术间隔分为无间隔、超过2个月间隔和超过3个月间隔组。在3590例慢性使用者中,超过2个月间隔组(106例,3.0%)长期术后阿片类药物使用停止率为53.8%,无间隔组为27.8%,逻辑回归分析显示OR 0.30(95%CI 0.20-0.46,P<0.001)。
要点
- 术前一年吗啡当量超过5000定义为慢性阿片类药物使用,共3590例(20.3%)。
- 超过2个月间隔组106例(3.0%),超过3个月间隔组41例(1.1%)。
- 超过2个月间隔组长期术后使用停止率53.8%,无间隔组27.8%,OR 0.30(95%CI 0.20-0.46,P<0.001)。
核心结论
- 末次阿片类药物处方在脊柱融合前超过2个月且供应量少于14天的慢性阿片类药物使用者,长期术后阿片类药物使用风险显著降低。
- 作者在慢性阿片类药物使用者中模拟了「阿片类药物撤药」,为当前临床实践和未来临床研究提供了初步参考点。
研究设计与样本
- 回顾性队列研究,使用Humana商业保险数据(2007年至2017年第一季度),研究初次颈段和腰/胸腰段脊柱融合。
- 术前一年吗啡当量超过5000定义为慢性术前阿片类药物使用。
- 根据末次阿片类药物处方(供应量少于14天)与脊柱融合之间的时间,将慢性阿片类药物使用者分为无间隔组、超过2个月间隔组和超过3个月间隔组。
- 主要结局指标为长期术后阿片类药物使用(术后3至12个月间吗啡当量超过5000)。
- 使用多变量逻辑回归分析研究「阿片类药物间隔」对长期术后阿片类药物使用风险的影响。
主要发现
- 共纳入17643例患者,其中3590例(20.3%)有慢性术前阿片类药物使用。
- 在慢性使用者中,超过3个月间隔组41例(1.1%),超过2个月间隔组106例(3.0%)。
- 超过2个月间隔组中53.8%的患者停止长期术后使用,而无间隔组为27.8%。
- 逻辑回归分析显示该关联显著(OR 0.30,95%CI 0.20-0.46,P<0.001)。
关键数值与推荐
- 慢性术前阿片类药物使用定义为术前一年吗啡当量超过5000。
- 长期术后阿片类药物使用定义为术后3至12个月间吗啡当量超过5000。
- 超过2个月间隔组相比无间隔组长期术后阿片类药物使用的OR为0.30(95%CI 0.20-0.46,P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective cohort. OBJECTIVE: To identify gaps in opioid prescription immediately prior to spinal fusion and to study the effect of such simulated "opioid weaning/elimination" on risk of long-term postoperative opioid use. SUMMARY OF BACKGROUND DATA: Numerous studies have described preoperative opioid duration and dose thresholds associated with sustained postoperative opioid use. However, the benefit and duration of preoperative opioid weaning before spinal fusion has not been elaborated. METHODS: Humana commercial insurance data (2007-Q1 2017) was used to study primary cervical and lumbar/thoracolumbar fusions. More than 5000 total morphine equivalents in the year before spinal fusion were classified as chronic preoperative opioid use. Based on time between last opioid prescription (<14-days' supply) and spinal fusion, chronic opioid users were divided as; no gap, >2-months gap (2G) and >3-months gap (3G). Primary outcome measure was long-term postoperative opioid use (>5000 total morphine equivalents between 3 and 12-mo postoperatively). The effect of "opioid gap" on risk of long-term postoperative opioid use was studied using multiple-variable logistic regression analyses. RESULTS: 17,643 patients were included, of whom 3590 (20.3%) had chronic preoperative opioid use. Of these patients, 41 (1.1%) were in the 3G group and 106 (3.0%) were in the 2G group. In the 2G group, 53.8% patients ceased to have long-term postoperative use as compared with 27.8% in NG group. This association was significant on logistic regression analysis (OR 0.30, 95% CI: 0.20-0.46, P < 0.001). CONCLUSIONS: Chronic opioid users whose last opioid prescription was >2-months prior to spinal fusion and less than 14-days' supply had significantly lower risk of long-term postoperative opioid use. We have simulated "opioid weaning" in chronic opioid users undergoing major spinal fusion and our analysis provides an initial reference point for current clinical practice and future clinical studies.Level of Evidence: 3.
引用
- Jain N, Phillips FM, Malik AT, et al. Preoperative Opioid Weaning Before Major Spinal Fusion: Simulated Data, Real-World Insights. Spine (Phila Pa 1976). 2021. PMID: 33038200. doi:10.1097/BRS.0000000000003744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。